Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | PLA2G4B | P0C869 | 3/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | RXRA | P19793 | 2/20 | 0.36 |
| ▸ | RXRB | P28702 | 2/20 | 0.36 |
| ▸ | NPC1 | O15118 | 2/20 | 0.36 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.36 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | CA7 | P43166 | 1/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | RARB | P10826 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2289273 | 0.94 | CA12 (0.39) | MAPTALDH1A1TSHRNPC1PDCD1 | |
| SCHEMBL28477026 | 0.84 | MAPT (0.39) | MAPTALDH1A1PLA2G4BRXRARXRB | |
| SCHEMBL28477024 | 0.77 | L3MBTL1 (0.35) | MAPTALDH1A1NPC1PDCD1CD274 | |
| SCHEMBL21459247 | 0.76 | — | — | |
| SCHEMBL28477025 | 0.74 | MAPT (0.40) | MAPTALDH1A1PLA2G4BTP53TSHR | |
| SCHEMBL16119470 | 0.72 | MAPT (0.47) | MAPTALDH1A1MAPK1TSHRRXRA | |
| SCHEMBL16115254 | 0.71 | KMT2A (0.37) | MAPTTP53TSHRNPC1L3MBTL1 | |
| SCHEMBL11807398 | 0.71 | TSHR (0.36) | MAPTALDH1A1MAPK1TP53TSHR | |
| SCHEMBL6227986 | 0.70 | MAPT (0.57) | MAPTALDH1A1PLA2G4BMAPK1TP53 | |
| SCHEMBL7109672 | 0.69 | ALDH1A1 (0.35) | MAPTALDH1A1MAPK1TP53TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12612516-B2 | Cationic curing agent, method for producing same and cationically curable composition | DEXERIALS CORPORATION (JP) | 2026-04-28 | — | — | US | disclosed |
| US-12297318-B2 | Curable resin composition | CANON KABUSHIKI KAISHA (JP) | 2025-05-13 | — | — | US | disclosed |
| US-12240942-B2 | Cationic curing agent, method for producing same and cationically curable composition | DEXERIALS CORPORATION (JP) | 2025-03-04 | — | — | US | disclosed |
| US-20250011582-A1 | LATENT CURING AGENT, PRODUCTION METHOD THEREFOR, AND CURABLE COMPOSITION | DEXERIALS CORPORATION (JP) | 2025-01-09 | — | — | US | disclosed |
| US-20240026149-A1 | CURING AGENT, METHOD OF PRODUCING CURING AGENT, AND CURABLE COMPOSITION | DEXERIALS CORPORATION (JP) | 2024-01-25 | — | — | US | disclosed |
| US-20230357488-A1 | CURABLE RESIN COMPOSITION | CANON KK (JP) | 2023-11-09 | — | — | US | disclosed |
| US-11795264-B2 | Latent curing agent and method for manufacturing same, composition for forming coating film, and cation-curable composition | DEXERIALS CORPORATION (JP) | 2023-10-24 | — | — | US | disclosed |
| US-11773208-B2 | Cationically curable composition and cured product production method | DEXERIALS CORPORATION (JP) | 2023-10-03 | — | — | US | disclosed |
| US-20230279217-A1 | CATIONIC CURING AGENT, METHOD FOR PRODUCING SAME AND CATIONICALLY CURABLE COMPOSITION | DEXERIALS CORPORATION (JP) | 2023-09-07 | — | — | US | disclosed |
| CN-116615482-A | Curing agent, method for producing same, and composition for curing | 迪睿合株式会社 | 2023-08-18 | — | — | CN | disclosed |
| US-7498375-B2 | Flame-retardant resin composition | POLYPLASTICS CO., LTD. (JP) | 2009-03-03 | — | — | US | disclosed |
| US-7205346-B2 | halogen-free, fireproof mixture of thermoplastic resins, containing phosphorus compounds, aromatic resins, nitrogen compounds, metal compounds, stabilizer agents and water repellants | POLYPLASTICS CO., LTD. (JP) | 2007-04-17 | — | — | US | disclosed |
| EP-1486536-B1 | FLAME-RETARDANT RESIN COMPOSITION | POLYPLASTICS CO (JP) | 2007-01-24 | — | — | EP | disclosed |
| US-7115677-B2 | Flame-retardant resin composition | POLYPLASTICS CO., LTD. (JP) | 2006-10-03 | — | — | US | disclosed |
| US-20050004292-A1 | Flame-retardant resin composition | POLYPLASTICS CO., LTD. (JP) | 2005-01-06 | — | — | US | disclosed |
| US-20040266916-A1 | Flame-retardant resin composition | POLYPLASTICS CO., LTD. (JP) | 2004-12-30 | — | — | US | disclosed |
| US-20040254270-A1 | Flame-retardant resin composition | POLYPLASTICS CO., LTD. (JP) | 2004-12-16 | — | — | US | disclosed |
| EP-1486536-A1 | FLAME-RETARDANT RESIN COMPOSITION | Polyplastics Co Ltd (JP) | 2004-12-15 | — | — | EP | disclosed |
| EP-1466946-A1 | FLAME-RETARDANT RESIN COMPOSITION | Polyplastics Co., Ltd. (JP) | 2004-10-13 | — | — | EP | disclosed |
| EP-1452567-A1 | FLAME-RETARDANT RESIN COMPOSITION | Polyplastics Co Ltd (JP) | 2004-09-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12612516-B2 | Cationic curing agent, method for producing same and cationically curable composition | SEM1, ARG1, PSMA1 | MAPT 3539/4885ALDH1A1 1124/4885PLA2G4B 2877/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.